Marjolein S. de Bruin-Weller

Best Publications

• Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

  Andrew Blauvelt;Marjolein de Bruin-Weller;Melinda Gooderham;Jennifer C. Cather

  1357
  Citations

• Epidemiology of atopic dermatitis in adults: Results from an international survey.

  S. Barbarot;S. Auziere;A. Gadkari;G. Girolomoni

  864
  Citations

• Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

  M. de Bruin-Weller;D. Thaçi;C.H. Smith;K. Reich

  523
  Citations

• ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.

  A. Wollenberg;Arnold Oranje;M. Deleuran;D. Simon

  495
  Citations

• ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

  A. Wollenberg;S. Christen-Zäch;A. Taieb;Carle Paul

  431
  Citations

• Conjunctivitis in dupilumab clinical trials.

  B. Akinlade;E. Guttman-Yassky;M. de Bruin-Weller;E. L. Simpson

  423
  Citations

• Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

  J. M. Oldhoff;U. Darsow;T. Werfel;K. Katzer

  376
  Citations

• Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.

  Kristian Reich;Henrique D Teixeira;Marjolein de Bruin-Weller;Thomas Bieber

  360
  Citations

• Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell–attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis

  DirkJan Hijnen;Marjolein de Bruin-Weller;Bert Oosting;Cristina Lebre

  261
  Citations

• When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

  Eric L. Simpson;Marjolein Bruin-Weller;Carsten Flohr;Michael R. Ardern-Jones

  249
  Citations

• Biomarkers for atopic dermatitis: a systematic review and meta-analysis.

  Judith Thijs;Todor Krastev;Stephan Weidinger;Constantinus F Buckens

  248
  Citations

• Dupilumab Shows Long-Term Safety and Efficacy in Patients With Moderate to Severe Atopic Dermatitis Enrolled in a Phase 3 Open-Label Extension Study

  Mette Deleuran;Diamant Thaçi;Lisa A. Beck;Marjolein de Bruin-Weller

  246
  Citations

• Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting

  Jochen Schmitt;Phyllis Spuls;Maarten Boers;Kim Thomas

  222
  Citations

• Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.

  Inge M. Haeck;Mirjam J. Knol;Onno ten Berge;Sara G.A. van Velsen

  221
  Citations

• Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment

  Andreas Wollenberg;Lieneke Ariens;Stephan Thurau;Chantal van Luijk

  203
  Citations

• Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

  Lawrence F. Eichenfield;Lawrence F. Eichenfield;Thomas Bieber;Lisa A. Beck;Eric L. Simpson

  186
  Citations

• Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

  A.M. Drucker;A.M. Drucker;A.M. Drucker;K. Eyerich;M.S. de Bruin-Weller;J.P. Thyssen

  184
  Citations

• Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis.

  Judith L. Thijs;Ian Strickland;Carla A.F.M. Bruijnzeel-Koomen;Stefan Nierkens

  175
  Citations

• Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: The Dutch Mite Avoidance Study

  Albert-Jan Oosting;Marjolein S. de Bruin-Weller;Ingrid Terreehorst;Zana Tempels-Pavlica

  163
  Citations

• Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis

  D S Bakker;L F M Ariens;C van Luijk;J van der Schaft

  149
  Citations